On November 15th, the National Health Commission held a press conference, where relevant officials introduced the recently formulated "Health China Action - Cardiovascular Disease Prevention and Control Action and Cancer Prevention and Control Action Implementation Plan (2023-2030)" (hereinafter referred to as the "Implementation Plan"). It is reported that the 5-year survival rate of cancer patients in China has steadily improved in recent years, and many advanced patients can survive with tumors for a long time, resulting in improved quality of life. In addition, the 5-year survival rate of breast cancer patients in China has reached 83%, which is basically consistent with the diagnosis and treatment level of developed countries. The 5-year survival rate of patients with esophageal cancer in China has been higher than that in Europe and the United States, and the incidence rate and mortality of esophageal cancer in some regions are declining. Scientific research plays an important role in the prevention and treatment of chronic diseases, "said Guo Yanhong, Director of the Medical Emergency Department of the National Health Commission. The country will continue to promote scientific research in the fields of cardiovascular and cerebrovascular diseases, cancer, and other chronic diseases. Strengthening innovation at the source and promoting the transformation of achievements are both emphasized in the "14th Five Year Plan" special plan for health and health technology innovation, and research on chronic disease prevention and control has been included in the development focus. By strengthening the organization and implementation of key projects such as "research on the prevention and control of major chronic non communicable diseases", China has formed a batch of high-quality evidence-based medicine research results. Guo Yanhong introduced that the implementation plan requires further strengthening scientific and technological innovation in weak links in the national science and technology plan, with a focus on supporting key technological breakthroughs in cardiovascular and cerebrovascular diseases, cancer prevention and control, and strengthening major source innovation and disruptive technological innovation in chronic disease prevention and control, leading the prevention and control technology to achieve original breakthroughs. The implementation plan also proposes to fully leverage the role of scientific and technological forces such as the National Medical Center and the National Clinical Medical Research Center, strengthen the scientific and technological demonstration research of advanced diagnosis and treatment technologies, clinical guideline specifications, and screening plans related to cardiovascular and cerebrovascular diseases, accelerate the promotion of scientific and technological innovation services, strengthen the evaluation of clinical research quality, and improve the overall scientific and technological level of chronic disease prevention and treatment in China. In addition, the implementation plan further emphasizes accelerating the transformation and promotion of achievements, and accelerating the application of basic cutting-edge research results in clinical and health industry development. By promoting the transformation and promotion of a number of research achievements and the construction of platforms, we will further enhance the level of cancer and cardiovascular disease prevention and control in China, and play a supportive and leading role in scientific research. Technological progress brings more survival opportunities for patients. "Technological progress brings more survival opportunities for patients." Wang Yongjun, Dean of Beijing Tiantan Hospital affiliated with Capital Medical University, said with facts: in 2021, China will take the lead in carrying out gene guided antiplatelet therapy in the world, bringing secondary prevention of cerebrovascular diseases into the era of precision medicine; In terms of vascular wall imaging using high field intensity magnetic resonance imaging and emergency use using low field intensity magnetic resonance imaging, China is at an international advanced level... "Some tumor prevention and treatment technologies in China have approached or reached international advanced levels." Zhang Yong, Secretary of the Party Committee of the National Cancer Center, stated that in terms of tumor prevention, the National Cancer Center has developed a joint screening plan based on high-risk concentration technology to explore the six most common types of cancer, Providing new ideas for international cancer screening; In terms of clinical treatment, China is the first to introduce new surgical techniques such as anatomical partial lobectomy and esophageal cancer exemption and prohibition